PharmaShots | Incisive News in 3 Shots

Subscribe Now

Global Development

Everest Enter into an Exclusive License Agreement with Sinovent and SinoMab to Develop and Commercialize XNW1011 for Renal Diseases

Everest Enter into an Exclusive License Agreement with Sinovent and SinoMab to Develop and Commercialize XNW1011 for Renal Disease...

September 20, 2021

WuXi Biologics and Vir Biotechnology Collaborate for the Global Development of Antibodies Against COVID-19

WuXi Biologics and Vir Biotechnology Collaborate for the Global Development of Antibodies Against COVID-19

February 26, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us